2019
DOI: 10.1167/iovs.18-24818
|View full text |Cite
|
Sign up to set email alerts
|

Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients

Abstract: WD and SY contributed equally to the work presented here and should therefore be regarded as equivalent first authors. AO and JvR contributed equally to the work presented here and should therefore be regarded as equivalent second authors. See the appendix for the members of the Rotterdam Ocular Melanoma Study Group.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(16 citation statements)
references
References 30 publications
1
14
0
1
Order By: Relevance
“…2016; Drabarek et al. 2019). Therefore, with our current results, it was difficult to establish an accurate cluster of prognostic stratification according to these two genes, as done by others (Drabarek et al.…”
Section: Discussionmentioning
confidence: 99%
“…2016; Drabarek et al. 2019). Therefore, with our current results, it was difficult to establish an accurate cluster of prognostic stratification according to these two genes, as done by others (Drabarek et al.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, lipid production has also been demonstrated in a subset of UM, but the drivers of this lipidic profile remain unclear [5,6]. The current report describes expression of HMG-CoA reductase in a lipid-producing UM with high-risk molecular cytogenetic (combined monosomy3 and high level 8q gain) [15,16] and mutational signatures. HMG-CoA reductase is the rate-controlling enzyme of the mevalonate lipid metabolic pathway, which plays crucial roles in oncogenesis and cancer cell stemness [17,18].…”
Section: Discussionmentioning
confidence: 81%
“…The role of the C3435T polymorphic marker of the ABCB1 gene in the development of early choroidal melanoma Svetlana V. Saakyan 1 , Mariam R. Khlgatyan 1 , Alexander Yu. Tsygankov 1 , Alexey M. Burdennyi 2 , Vitaly I. Loginov 2 метилирование промоторных районов гена RASSF1A, полиморфизм гена ABCB1/MDR1, мутации в гене BAP1 и изменение экспрессии белка BAP1 [8,14]. Указанные молекулярно-генетические маркеры позволяют дифференцировать УМ от других первичных опухолей и прогнозировать течение опухолевого процесса [8].…”
Section: Gnaq Gna11 Plcb4 Cysltr2 Sf3b1 Eif1axunclassified